commiss decis relat proceed pursuant articl ec treati case iv glaxo wellcom notif iv aseprofar fedifar complaint iv spain pharma complaint iv bai complaint iv eaepc complaint notifi document number english text authent text eea relev ec commiss european commun regard treati establish european commun regard council regul februari regul implement articl treati amend regul ec articl thereof regard commiss juli initi proceed case undertak concern opportun make view object rais commiss pursuant articl regul articl commiss regul ec decemb hear parti proceed articl ec treati consult advisori committe restrict practic domin posit fact introduct decis concern compat articl ec treati glaxo wellcom sa sale condit pharmaceut product suppli spanish wholesal pursuant claus sale condit glaxo wellcom sa oper distinct hand price charg wholesal resel product spanish pharmaci hospit reimburs end spain hand price charg wholesal export product price higher appli case domest resal procedur march glaxo wellcom sa hereinaft quot gw sa quot notifi sale condit hereinaft quot sale condit quot view obtain neg clearanc pursuant articl regul altern exempt pursuant articl regul june gw sa inform commiss slight modif calcul export price older product provid commiss list quot spanish quot price valid june juli gw sa parent compani glaxo wellcom plc hereinaft gw plc transmit supplementari notif draw commiss attent quot factor specif glaxo wellcom busi spain affect busi glaxo wellcom subsidiari eu quot subsequ number wholesal wholesal associ lodg complaint commiss pursuant articl regul complaint argu gw sa sale condit infring articl treati add condit violat articl treati complaint receiv undertak associ undertak aseprofar quot associación de exportador español de producto farmacéutico quot spanish profession organis consist pharmaceut wholesal centro farmacéutico asturiano sa unyexport medicamento sa euroserv sa galénica sa farmacéutica aragonesa centro farmacéutico nacion sa aseprofar object defenc freedom export interst circul pharmaceut good pursuant rule european union total turnov wholesal eur billion esp billion spanish profession organis compris associ wholesal call fedifar quot federación nacion de asociacion de mayorista distribuidor de especialidad farmacéutica producto parafarmacéutico quot interven support aseprofar complaint spain pharma sa individu spanish wholesal pharmaceut product achiev turnov eur million esp billion quarter deriv export member state bundesvervand der arzneimittel importeur bai associ german import pharmaceut product european associ euro pharmaceut compani eaepc repres interest nation associ import export pharmaceut product locat germani bai spain aseprofar unit kingdom denmark netherland norwai sweden septemb commiss gw plc warn letter point sale condit appear infring articl treati septemb gw plc submit memorandum entitl quot respons gw plc legal argument commiss letter septemb quot hereinaft refer quot gw memorandum quot subsequ submit econom studi analys effect parallel import entitl quot gw spanish price system approach parallel import quot hereinaft refer quot london econom studi quot quot advers effect parallel import consum welfar quot hereinaft refer quot prof rei studi quot juli commiss adopt statement object gw plc repli novemb hereinaft refer quot repli quot repli contain studi pharmaceut price hereinaft refer quot frontier econom studi quot gw opportun make view oral hear place decemb complaint aseprofar spain pharma eaepc particip hear european feder pharmaceut industri associ efpia particip support gw plc decemb commiss formal request inform gw plc number issu discuss oral hear gw plc repli februari week submit comment studi submit aseprofar quot effect parallel import social welfar quot undertaken professor corchón marín hereinaft refer quot prof corchon marin studi quot gw plc comment studi embodi studi produc frontier econom hereinaft refer quot frontier econom studi ii quot prepar professor rei hereinaft refer quot prof rei studi ii quot eaepc submit written version intervent oral hear document entitl quot parallel trade pharmaceut quot gw plc comment februari parti gw sale condit spain glaxo wellcom sa state recit gw sa spanish subsidiari gw plc main activ creation discoveri develop manufactur market medicin spain compani oper directli subsidiari wellcom farmacéutica sa allen farmacéutica sa duncan farmacéutica sa form econom unit total turnov eur million esp billion gw sa form part glaxo wellcom group major global player manufactur pharmaceut product countri sell countri gw plc turnov gbp billion eur billion gw plc merg pharmaceut compani smithklin beecham form entiti glaxosmithklin plc merger clear commiss section supplementari notif gw plc quot glaxo wellcom effect ownership control glaxo wellcom sa firm constitut singl undertak purpos commun law quot emerg section notif quot glaxo wellcom quot refer glaxo wellcom plc present decis refer glaxo wellcom gw design entir group make specif refer gw sa gw plc spanish wholesal parti spanish wholesal subscrib sale condit hundr pharmaceut wholesal activ spain gw sa transmit sale condit wholesal total wholesal sale repres gw sa sale spain accept condit includ gw sa main client cofar reguladora de compra del mediterráneo cecofar saga galénica federació farmacéutica safa galenica rais reserv legal sale condit federació farmacéutica state compli oblig claus sale condit product fund social secur public fund wholesal subscrib sale condit belong gw sa main client cofaran express doubt legal condit product concern gw sa point sale condit appli total pharmaceut product repli gw specifi product prescript drug complet list product annex decis total number take account fact drug sold dosag packag form lamict mg tablet mg tablet mg tablet mg tablet drug administ wai ventolin inhal inject relev pharmaceut product cover varieti field drug function respiratori system bronchodil asthma nasal prepar antihistamin drug treatment infect prepar nausea ulcer dermatolog product immunomodul agent anti malaria drug hormon prepar cardiac drug prepar central nervou system musculo skelet system otolog product herp migrain supplementari notif juli gw plc submit list product consid prime candid parallel trade spain unit kingdom becotid beconas beclofort flixotid imigran lamict serev ventolin number account fact drug sold dosag packag form administ wai total number fact account respons decemb formal request inform gw plc provid market share june june member state product cover sale condit gw plc calcul market share basi data collect medic research compani intern medic statist im data relat class drug belong level quot anatom therapeut classif quot atc drawn ephmra european pharmaceut market research associ atc classif group pharmaceut special therapeut class atc level correspond therapeut main group atc level reflect therapeut pharmacolog subgroup tabl annex drawn commiss focus member state show gw market share valid june tabl give market share product market data specif spanish brand name ad bracket figur reflect sale valu express gbp constant exchang rate emerg tabl gw market share product consid prime candid parallel trade substanti becotid beclofort flixotid serev ventolin belong level class bronchodil asthma class drug gw hold commun wide share peak unit kingdom uk share beconas part level class amount lamict part level anti epilept class gw commun wide share uk share final imigran yield share commun unit kingdom gw sale condit spain content enforc claus sale condit notifi sale condit enter forc march claus deal price charg gw pharmaceut special wholesal quot industri price quot read quot pursuant provis subsect paragraph articl law decemb medicin price pharmaceut product gw sa subsidiari compani event exce maximum industri price establish spanish health author factor applic legal rule present aforement pharmaceut product financ fund spanish social secur spanish public fund acquir pharmaceut product subsequ market nation level pharmaci spanish hospit absenc factor case spanish law full freedom laboratori set price pharmaceut product gw sa subsidiari fix price pharmaceut product real object discriminatori econom criteria complet irrespect destin product determin purchas warehous gw sa subsidiari compani appli pharmaceut product price basi intern econom survei initi propos spanish health author object updat take account increas cost live accord provis subsect paragraph articl law decemb medicin prior spanish legisl set price medicin quot term claus indent gw sa offer claus price spanish wholesal condit resel drug end destin pharmaci hospit locat spain claus prevent spanish wholesal export drug spain purchas drug price case export pai higher price provid claus tabl notif juli gw plc state object claus quot consum spain obtain gw product prejud abil gw fund research develop commun distort abil gw distributor includ base spain compet basi price servic effici commun quot submit claus quot es block intend block sale distributor establish spain countri spain protect distributor establish spain spanish distributor advantag due superior effici differ exchang rate quot gw plc state claus affect trade spain member state acknowledg quot practic princip effect claus trade spain uk greater part spanish sourc parallel import sold market uk quot enforc claus sale condit gw initi suspend suppli wholesal refus subscrib sale condit enter forc march state reason avoid discrimin wholesal accept condit spain pharma sa confirm refus accept sale condit longer suppli gw sa member aseprofar euroserv cefena cefasa suppli reduc reason gw explain monitor implement sale condit wholesal subscrib stress practic mean ensur strict complianc claus case cofar competitor inform gw sa export question gw sa cofar acknowledg exist export declar place mistak gw sa request payment supplementari invoic cover differ claus price case cecofar reguladora de compra del mediterráneo nafarco molina serrano cofex hefagra cofa gw sa compar volum product acquir wholesal claus price im data wholesal domest sale actual sale spain appear significantli lower suppli made claus price gw sa request wholesal amount export product acquir claus price period march entri forc sale condit octob entri forc interim measur order spanish competit author recit view send supplementari invoic cover differ claus price wholesal repli export product march repli commiss inform request octob gw sa point valid reason termin commerci relat wholesal repeatedli infring sale condit systemat refus pai supplementari invoic octob spanish competit defens tribun quot tribun de defensa de la competencia quot adopt interim measur order gw sa suspend applic claus period month gw sa appeal quot audiencia nacion quot nation spanish court interim measur pend appeal gw sa suppli product wholesal maximum wholesal claus price sign sale condit irrespect destin domest abroad purchas product gw order significantli exceed gw sa sale product forecast januari gw sa decid longer suppli total quantiti order wholesal sign sale condit alloc volum base histor order pattern respect gw quot wholesal suppos carri activ defin territori spain high volum order endang legitim object legal oblig gw sa maintain adequ balanc suppli product spain quot aseprofar confirm gw suppli quantiti request member shortli expiri interim measur juli aseprofar fedifar request extens measur quot tribun de defensa de la competencia quot grant request prolong interim measur enter forc wholesal associ fail desposit secur date gw sa refrain implement sale condit parallel trade pharmaceut product commun impact nation regulatori framework currenc fluctuat price pharmaceut product vari member state price differ creat opportun parallel trade quot kei driver parallel trade quot oral hear gw plc state intra commun trade prescript medicin estim increas period year ot total sale price differ influenc factor main factor highlight section regulatori framework member state currenc fluctuat factor structur absenc harmonis commun level nation author member state enact enforc rule aim control directli indirectli sale price charg pharmaceut compani determin purchas cost end consum state budget order achiev cost save member state seek promot parallel trade recit factor natur cyclic currenc countri target parallel trader high price level depreci parallel trade decreas increas currenc gain gw submit tabl tabl broad pictur level pharmaceut price countri note footnot tabl reflect gw comment tabl member state enact measur stimul parallel trade final rough estim magnitud parallel trade commun degre parallel import appear vari member state tabl parallel import higher market share unit kingdom denmark netherland unit kingdom gw estim recit percentag correspond larg nation health servic estim recit tabl incent price parallel import gt tabl gt gw sa sale condit quot intend remedi advers effect creat differ spanish uk system pharmaceut price regul limit impact low price mandat spanish govern spain quot descript recit deal primarili regulatori framework member state inform member state view fact claus price appli irrespect final destin export product data currenc fluctuat regulatori framework member state member state oper system aim control vari degre price categori pharmaceut price control direct maximum sale price indirect profit cap maximum reimburs level tabl show member state enact measur aim encourag parallel trade recit short descript regulatori framework spain unit kingdom member state descript focus price control sensu stricto reimburs scheme il inform incent parallel trade spain spain maximum price fix reimburs prescript drug basic legisl contain articl law lei del medicamento modifi success articl law gener pharmaceut price set basi object verifi criteria articl law stipul ministri health consum set maximum industri price pharmaceut product financ nation social secur system mention recit industri price price pharmaceut compani charg wholesal gw hat notifi sale condit commiss law introduc amend articl explicitli maximum industri price appli product dispens spain financ social secur fund state fund relat health ministri set margin commercialis quot concepto correspondient la comercialización quot articl law margin wholesal pharmaci ministri de facto set maximum retail price maximum industri price wholesal pharmaci margin ministri set maximum industri price accord procedur set royal decre price set procedur start request pharmaceut compani pursuant articl royal decre compani submit technic account financi document prepar econom report report basi determin price pharmaceut product compani provid detail studi reflect real cost involv time develop pharmaceut product articl royal decre requir nation administr account quot complet cost includ cost involv research develop quot set price administr set compani profit refer quot technic report econom financi posit compani quot independ individu price applic gener level price pharmaceut spain discuss ministri health pharmaceut produc associ farmindustria septemb farmindustria decid termin agreement ministri health pharmaceut expenditur articl royal decre enabl pharmaceut compani appli price increas public health technic busi budgetari circumst requir increas gw plc acknowledg gw sa obtain price increas occas spanish author agre price increas serev imigran lamict dosag packag form price increas substanti imigran maximum unit price rose esp esp lamict mg tablet authoris price esp previou price esp product offer packag tablet juli gw sa notif substanti price increas obtain ventolin inh mg authoris maximum price unit rose esp esp worth note abovement product gw sa obtain price increas serev imigran lamict ventolin belong group product gw plc claim main candid parallel export spain unit kingdom recit unit kingdom price control govern pharmaceut price regul scheme ppr agre manufactur uk nation health servic nh scheme cover licens brand medicin sold nh ppr forc time gw sa notif ran octob septemb present ppr cover period octob octob pharmaceut compani set price product freeli profit cap ppr total home sale nh medicin unit kingdom exce gbp million million scheme ppr cap profit set quot target quot return capit emploi sale target return capit quot roc quot base histor averag invest capit level roc nh gener roc determin compani liabil repai excess profit lower roc decid price increas applic compani allow deduct percentag sale revenu quot gross quot profit reward amp invest gw discount amount manufactur profit exce target roc measur price reduct restrict suspens price increas request manufactur repay excess profit octob ppr introduc gener price cut reimburs drug pharmaceut produc pharmaceut compani option meet price cut reduc price modul price reduc price drug substanti price remain unchang level cut period month januari subsequ modul agre price modul cost neutral mean price chang product implement cut respect unit kingdom reimburs scheme patient pai uniform flat fee gbp prescript drug purchas prescript contracept medicin free categori patient year poor chronic sick exempt payment sale made uk pharmacist receiv fix reimburs fee nh fee set refer manufactur list price mean pharmacist receiv fee irrespect actual purchas cost incur parallel import cheaper product yield fee domest purchas manufactur list price nh oper quot claw back quot mechan vi vi pharmacist account parallel trade nh automat deduct manufactur list price discount quot claw back quot rang deduct base assumpt correspond save uk pharmacist achiev year place order parallel trader pharmacist face claw back irrespect dispens parallel trade product save correspond figur claw back mechan aim ensur save partial transfer nh taxpay mechan aim primarili avoid unjust enrich intermediari pharmacist encourag increas parallel trade purchas drug parallel trade excess refer point claw back mechan competitor purchas parallel trade drug level bui requir domest london econom studi submit gw explicitli state claw back system penalis trader engag level parallel trade april nh set nation institut clinic excel nice institut make recommend nh patient doctor medicin medic equip clinic procedur context examin cost effect medic treatment medicin member state spain member state oper direct price control system system cover medicin belgium confin prescript drug netherland reimburs drug denmark franc itali sweden countri maximum price set basi wide varieti paramet includ actual averag price level member state belgium finland itali sweden netherland basi gener reason test denmark countri price fix franc pharmaceut compani involv regulatori process market player countri principl free price medicin unit kingdom germani explain recit unit kingdom cap profit brand drug sold nh germani member state mention exert indirect price control reimburs scheme reimburs scheme form countri oper refer price system germani netherland sweden denmark mean nation author reimburs drug authoris reimburs amount equal refer price set countri denmark sweden refer price calcul basi price cheapest product group product sold higher price patient pai excess scope refer price system vari germani cover patent drug member state patient receiv reimburs express percentag sale price franc countri patient pai flat fee type drug remain amount born nation health system unit kingdom combin mechan occur case patient principl receiv reimburs express percentag sale price order avoid amount paid excess nation author requir payment modest flat fee belgium finland itali special regim benefit social group pension invalid widow countri denmark sweden patient reimburs annual expens drug stai level tabl show member state oper measur encourag parallel trade netherland pharmacist paid domest wholesal price fix fee unit kingdom pharmacist find cheaper product parallel import inform dutch health ministri receiv fee increas profit margin incent engag parallel trade claw back mechan adjust profit denmark gw parallel trade penetr pharmacist legal oblig inform patient order drug prescrib doctor cheaper substitut includ parallel trade product member state germani sweden tabl incent parallel import exist pharmacist encourag parallel import good report swedish competit author counti recommend pharmaci sell cheapest medicin includ parallel product germani pursuant amend paragraph social secur act sozialgesetzbuch pharmacist oblig sell cheap import pharmaceut product circumst spell contract pharmaci health insur compani quot krankenkassen quot quot import förderklausel quot import promot claus ministri health claus stimul price competit ultim lead save health insur scheme save indirectli benefit patient financ scheme monthli obligatori health insur contribut currenc fluctuat impact currenc fluctuat parallel trade univers acknowledg fluctuat disappear januari member state belong euro zone econom monetari union unit kingdom denmark sweden expos currenc fluctuat studi quot parallel import strategi quot state quot past exchang risk major complic factor exchang rate movement quickli erod elimin price differenti import attempt limit risk bui forward major currenc requir year currenc code ec member state steadi main except sterl uk strength sterl recent month major posit impact profit ratio import uk quot gw note quot appreci pound caus uk price increas rel eu countri quot octob april gbp esp exchang rate rose annex decis reflect appreci british pound octob rate refer point month onward exchang rate steadili increas reach peak april month gw sa notifi sale condit fell exchang rate januari compar rate decemb british pound appreci period relev year gw provid data parallel trade product recit parallel trade gw product commun impact gw sale condit recit gw sa sale condit cover product gw plc product prime candid parallel trade dosag mode administr packag size account product gwc plc provid data price level member state luxembourg submit spanish price artifici low gw plc data volum parallel trade product focus export spain import unit kingdom claus sale condit appli product list annex decis commiss examin price level product identifi gw plc interest parallel trader price level valid april examin section section consid specif domest price level spain unit kingdom claus price appli irrespect final destin product export spain section account gw plc inform volum parallel trade product period essenti prior introduct sale condit spain section describ potenti impact claus price parallel trade member state compar price prevail member state level price gw gw price commun tabl overview gw price product gw plc parallel trade mot signific commun april price unit price express esp claus price spain entri forc condit march price member state valid april convert esp march exchang rate suppli gw price ventolin becotid shown separ tabl claus claus price chang march price tabl valid june express esp convers rate date tabl glaxo wellcom price commun luxembourg april gt tabl gt sourc calcul base data suppli glaxo wellcom letter document repli frontier econom studi annex tabl glaxo wellcom price commun luxembourg june gt tabl gt sourc calcul base data suppli glaxo wellcom letter june document letter document repli frontier econom studi annex gw price spain unit kingdom compar commun averag tabl compar claus price domest sale spain sourc countri parallel trade gw gw price unit kingdom target countri parallel trade gw commun averag price tabl limit assess concret market opportun parallel trader wish export spain unit kingdom tabl show spanish price quot artifici low quot contend gw plc vast major uk price exce commun averag tabl gt tabl gt gt tabl gt spain half claus price commun averag price lamict mg mg averag consider commun averag commun averag becotid product introduc market ventolin gw sa obtain price increas reduc price differ commun averag tabl unit kingdom price product higher commun averag price case gap widen serev inh mg gap visibl product launch recent year flixotid imigran lamict serev volum parallel trade gw product period juli gw plc suppli estim volum parallel trade product year loss sale revenu parallel trade caus set figur concern inter alia parallel import gw product sourc unit kingdom import estim gbp million gbp million gbp million repres uk sale take account sale revenu earn unit kingdom gw estim net loss revenu gbp million gbp million gbp million set data relat parallel import gw product highest volum parallel import sourc unit kingdom import amount gbp million gbp million gbp million repres gw uk sale product set figur show parallel import lead product unit kingdom spain amount gbp million total uk sale gbp million total uk sale gbp million gw total uk sale offset revenu gain higher sale spain gw estim net loss revenu result import amount gbp million year gbp million comparison set data show share import unit kingdom spain compar import sourc larg remain gbp million gbp million gbp million gbp million gbp million gbp million word absolut volum spanish sourc import increas year share import unit kingdom remain stabl octob januari commiss ask gw provid detail inform parallel trade import product commiss request precis data volum spain sourc parallel trade member state product volum import unit kingdom mother member state includ spain product repli decemb gw provid estim parallel export spain countri destin stress quot confid figur provid accur reflect volum product leav spain quot gw recal inter alia parallel trade li formal audit distribut channel pan european audit parallel trade import unit kingdom estim indic sourc countri estim repli relat product dosag packag form product ad omit repli date februari gw plc state quot basi gw refin estim volum quot experi lead conclud quot vast major parallel import spain find uk remain export divid germani netherland denmark sweden quot parallel import unit kingdom gw estim import origin spain gw admit quot data real deriv seri assumpt quot quot real empir basi estim quot quot caution data provid reliabl quot impact gw sa sale condit parallel trade product tabl reliabl start point assess impact introduct gw sa claus price abil spanish wholesal export gw product april price prevail member state lower claus price case mean spanish wholesal econom case export product case purchas product claus price claus price impact parallel trade case case price member state situat claus price claus price claus price depriv wholesal opportun export product parallel trade exclud remain case price member state claus price claus price price render parallel trade imposs make export econom profit consequ parallel trade imped case short separ tabl becotid ventolin tabl becotid claus price reduc june ventolin claus price increas recit claus price reduc date result parallel trade becotid theori countri opportun parallel trade claus price ventolin improv tabl account fact spanish wholesal incur cost ad price bui drug pharmaceut compani cost cover servic packag transport reliabl data magnitud cost oral hear gw plc argu product success blockbust product cost exce complain state cost amount basi tabl reproduc figur appear tabl add spanish price assum cost materi domest sale export underestim packag transport cost relat export allow wholesal cost doe chang result dramat cost scenario case parallel trade exclud claus price case trade imped cost scenario parallel trade exclud case imped case tabl effect glaxo wellcom price system parallel trade spain member state luxembourg grei area show exclus parallel trade case amp lt nation price amp lt bold figur show product trade made profit gw price case amp lt amp lt nation price slash product comparison price march price member state april convert esp march exchang rate price esp unit product gt tabl gt price june price member state april convert esp june exchang rate price esp unit product gt tabl gt tabl effect glaxo wellcom price system increas margin parallel trade spain member state luxembourg grei area show exclus parallel trade case amp lt nation price amp lt bold figur show product trade made profit gw price case amp lt amp lt nation price slash product comparison price march price member state april convert esp march exchang rate price esp unit product gt tabl gt price june price member state april convert esp june exchang rate price esp unit product gt tabl gt tabl effect glaxo wellcom price system increas margin parallel trade spain member state luxembourg grei area show exclus parallel trade case amp lt nation price amp lt bold figur show product trade made profit gw price case amp lt amp lt nation price slash product comparison price march price member state april convert esp march exchang rate price esp unit product gt tabl gt price june price member state april convert esp june exchang rate price esp unit product gt tabl gt glaxo wellcom main argument supplementari notif juli gw plc explain detail reason appli neg clearanc altern exempt expand reason repli summari gw plc argument drawn document degre overlap argument made context articl advanc context articl articl treati claus amount export ban dual price object restrict competit gw admit claus sale condit spain liabl restrict parallel trade member state state claus amount export ban leav scope parallel export commerci basi equat system dual price gw sa free set domest wholesal price gw speak term dual price supplier determin price product suppli agreement restrict parallel import equival export ban system dual price object restrict competit mean articl regard se illeg assess restrict effect made claus produc restrict effect competit gw incumb commiss assess restrict effect notifi agreement econom legal context agreement object restrict competit gw view claus produc effect correct compens distort competit result state intervent case spain maximum wholesal price absenc harmonis nation rule price prescript medicin effect resembl produc claus agreement consid commiss decis relat metro distil victual villeroi boch final gw argu claus enhanc consum welfar limit trade parallel trade harm consum spain caus harm uk consum claus compens distort competit creat spain nation author plai doubl role pharmaceut sector regul drug sale price directli effect purchas drug reimburs patient nation author decid regul impos low sale price drug order achiev budgetari save purchas reimburs entiti undermin price polici nation author approv higher price free price place higher prioriti research develop innov drug recognis requir higher sale revenu pharmaceut compani actual distort competit trigger parallel trade low price sourc countri higher price target countri econom theori trade flow forc price tot level sourc countri turn put risk amp invest target countri frustrat countri polici promot invest present case spain creat distort competit system maximum wholesal price aim reduc nation healthcar budget put risk polici member state includ unit kingdom adequ amp invest prioriti analog distil victual metro villeroi boch case restrict effect produc claus sale condit similar agreement neg clearanc distil victual case distil prohibit victual oper duti free trade suppli custom good duti free end consumpt resal duti free market gw perceiv analog hand duti free segment spanish market special maximum price prevail hand duti free segment export market higher price appli claus intend remedi distort competit similar distort creat dual distribut wholesal obtain product lower price retail sell directli end user competit retail commiss grant neg clearanc compani prevent wholesal metro villeroi boch claus enhanc consum welfar parallel trade harm consum spain gw estim lost revenu due parallel trade lead product spain unit kingdom amount gbp million recit harm gw respect hand lost sale repres net direct loss gbp million account extra sale revenu earn sourc countri hand loss gbp million domest uk sale reduc discount recit gw allow deduct ppr context nh profit cap reduct amount gbp million gw conclud quot circumst limit introduct product spain quot gw sa price polici harm uk consum uk nation health servic patient pai cost prescrib pharmaceut product except minim flat rate payment cost born state real consum unit kingdom govern reimburs patient parallel trade benefit govern limit extent claw back mechan recit gw stress govern set mechan intent benefit parallel trade prevent uk intermediari pharmacist obtain unjust enrich purchas cheaper parallel import product receiv reimburs fee base domest unit kingdom price articl treati discuss detail cumul condit exempt set articl gw formul argument gener natur notif juli develop argument repli larg argument argument submiss made context articl gw argu articl interpret light provis articl treati refer court judgement merck primecrouwn centrafarm winthrop gw view demonstr privat measur imped parallel trade exempt plead balanc neg impact restrict benefit assert parti bilan économiqu present case rule favour benefit achiev sale condit gener argument restat specif argument relat condit set articl summaris gener argument articl combin applic articl articl subsidiar articl articl absenc harmonis nation regul pharmaceut price commiss parallel import advanc goal market integr price differ reflect polici decis member state effect parallel trade impos fiscal budgetari industri polici member state econom social cohes articl articl gw price polici spain ensur adequ suppli innov medicin spanish market argu artifici low price allow spanish govern led signific delai applic product licenc spain actual market gw product case product reach market spain year market unit kingdom competit amp articl articl gw consider length explain long term detriment effect parallel trade pharmaceut sector effect reduc revenu compani target countri price push level sourc countri gw figur nera report loss industri refer loss unit kingdom period recit long term effect reduc fund basi research product develop due loss revenu gw reduc total amp invest quot partli result lower anticip sale revenu quot gw add trend contribut migrat pharmaceut industri amp effort countri usa higher profit earn judgment merck primecrown centrafarm winthrop gw argu court justic recognis legitimaci privat measur reduc parallel trade commiss support measur exempt pursuant articl merck primecrown court acknowledg quot imposit price control factor condit distort competit member state quot observ quot settl distort price legisl member state remedi measur commun author adopt member state measur incompat rule free movement quot gw quot measur commun author quot includ individu exempt pursuant articl respect gw reli centrafarm winthrop court measur includ quot exercis power competit field quot bilan économiqu argument notif juli gw state unit kingdom govern estim annual save parallel import nh claw back mechan gbp million benefit small compar direct net loss gbp million due import spain recit loss gbp million gw allow amp budget ppr due import sourc footnot conclud real beneficiari parallel import parallel import repli gw expand argument point neg effect parallel import exacerb distort competit creat member state intervent lead price deviat optim welfar enhanc price delai product introduct lower price countri classic benefit consum high price countri lower purchas price exist princip consum countri govern fund purchas necessarili regard lower price gener parallel import benefit lead invest amp parallel trade pharmaceut good involv arbitrag commerci specul specif argument condit set articl condit promot technic progress gw reiter argument import amp critic competit paramet pharmaceut sector neg impact parallel trade amp financ amp competit paramet gw state rate amp expenditur repres approxim turnov amp invest amount gbp billion rate amp expenditur high compani oper market intern fund major sourc fund research project sound econom reason includ issu screen commit neg impact parallel trade amp financ gw host figur size amp invest direct indirect loss amp due parallel trade import sale revenu amp demonstr neg impact parallel trade state averag amp invest develop singl product gbp million urg commiss dismiss small percentag decreas amp de minimi amp engag amp led discoveri major product success unpredict opportun cost infinit gw restat figur direct loss amp incur gw plc result parallel trade lead product spain offset extra revenu sale spain loss amount gbp million gbp recit gw reinvest pre tax profit amp meant reduct amp budget gbp million period gbp million repres reduct contribut gw plc sale gw world wide amp budget gbp million reduct quot suffici cover develop cost number product develop licens gw forc cancel postpon result prioritis scarc resourc quot gw acknowledg difficult identifi project realis continu substanti sum oral hear mention project fund due insuffici financ gw repeat parallel trade unit kingdom sourc spain caus indirect loss amp led reduct discount nh deduct uk sale determin basi cap profit loss revenu amount gbp million parallel trade gw product sourc recit gbp million parallel trade lead product spain recit led reduct allow discount gbp million sourc gbp million spain footnot effect reduc gw quot permiss amp budget quot gw final stress pharmaceut compani make amp invest decis basi anticip stream return depend patent obtain directli relat sale revenu net product cost turn depend expect price charg quantiti sold gw illustr point refer increas amp expenditur time period period gw succeed bring number success innov product market zantac import product account word wide revenu condit improv distribut gw parallel trade detriment distribut pharmaceut product respect start parallel trade interfer produc abil plan distribut ration lead shortag sourc countri oversuppli target countri cofar largest domest spanish wholesal associ spanish laboratori complain shortag spain parallel trade disrupt produc distribut system remov incent mean wholesal provid level servic remuner final combin low domest price parallel trade give rise provid strong disincent rapid introduct innov medicin low price countri result market delai product detriment effect result differ price due exchang rate fluctuat lower cost distributor excus toler reflect work free market contrast effect result member state intervent justifi sale condit provid object improv distribut remedi neg effect parallel trade condit consum benefit gw argu consum profit enhanc amp activ improv distribut benefit consum benefit nation govern involv gw system unit kingdom achiev goal stimul amp permit spanish govern share benefit set maximum wholesal price domest condit indispens gw consid claus indispens reduc distort competit creat spain contempl action spanish author basi articl treati ground maximum wholesal price limit import quot advis absenc evid spanish price system higher price product produc spain system view restrict import light lack harmonis pharmaceut price quot fourth condit substanti restrict competit gw refer submiss context articl quot competit quot creat parallel import pharmaceut product unit kingdom competit benefit consum signific degre serv expens unit kingdom govern profit parallel trader sale parallel import exce level assum ppr gw note oper exclus distribut countri affect parallel import spain intraband competit continu respect gw product sale condit forc argument present complain complain regard claus gw sa sale condit agreement put place system dual price imped parallel trade system se illeg exempt aseprofar claim parallel trade constitut sourc competit patent medicin eaepc stress notifi system influenc avail parallel trade medicin member state unit kingdom parallel trade yield benefit consum high price countri aseprofar reject argument govern opportun foster amp accept high price mechan ineffici guarante high profit necessarili lead desir level amp desir level amp event govern revert altern direct mean stimul amp subsidis activ aseprofar cast doubt exist conflict polici goal spain unit kingdom nh wish stop discourag parallel trade reimburs pharmacist basi actual purchas cost pai fix fee unrel cost ii legal assess articl treati agreement undertak commiss consid claus sale condit constitut agreement gw sa subsidiari spanish wholesal subscrib condit receiv copi thereof recit gw plc disput condit sale constitut agreement undertak mean articl relev market commiss defin relev product market refer quot anatom therapeut classif quot atc recogn occasion accept atc classif drawn ephmra gw reli present case pharmaceut case commiss atc level reflect therapeut pharmacolog subgroup drug start point analysi specif case market definit narrow wider atc level ultim substitut product depend indic approv case prescript drug depend diagnosi prescrib doctor supplementari notif juli gw provid product market share data base level atc classif gw observ spanish price system problem caus parallel import give rise issu individu product cover agreement issu point wider product market compris prescript medicin take account observ fact sale condit appli gw product sold spain total affect parallel trade commun determin precis gw market share product purpos decis reason dwell scope relev geograph market commiss decis adopt hitherto scope defin nation present case commiss divert number factor includ price reimburs regul brand pack strategi distribut system prescrib habit physician reflect market share product member state stage commun harmonis limit technic requir medicin entri forc procedur enabl pharmaceut compani appli european agenc evalu medicin product purpos obtain singl market authoris entir commun develop pharmaceut compani continu nation market authoris procedur restrict competit commiss address argument submit gw context articl submit price polici spain enhanc consum welfar limit form trade parallel trade harm consum spain caus harm uk consum gw reiter argument detail context articl address context claus tantamount export ban dual price system object imped parallel trade gw contend sale condit block intend block export spanish wholesal advantag due superior effici differ exchang rate recit admit london econom studi agreement quot intend reduc incent spanish trader engag parallel trade prescript medicin purchas low price set spanish govern quot gw object imped parallel trade oblig spanish wholesal purchas drug price higher maximum industri price domest sale effect exclus restrict parallel trade shown regard gw lead product gw consid subject parallel trade claus price exclud restrict parallel trade larg major case recit claus price exclud trade make econom uninterest wholesal case case account wholesal cost percentag increas slightli wholesal cost margin ad domest export price case cost margin scenario case case claus price imped parallel trade make econom interest wholesal case admittedli percentag decreas add wholesal cost case cost case claus produc effect tantamount export ban consider number case imped parallel trade case system dual price analog export ban commiss impos fine pharmaceut compani polici aim ban parallel trade sandoz prohibit practic compani displai word quot export prohibit quot number year sale invoic court justic upheld commiss decis price polici make econom uninterest wholesal indulg parallel trade consid effect outright contractu export ban exclud trade involv principl cost monitor complianc parallel drawn commiss decis distil quot applic price allow spirit export applic custom price spirit export spirit unit kingdom consumpt attempt imped parallel import unit kingdom eec countri unit kingdom object formal export prohibit regard effici discourag export quot analog dual price extent claus price render parallel trade costli econom interest gw polici equat system dual price kind prohibit moët chandon distil gosm martel case commiss qualifi claus reserv list price champagn product consumpt unit kingdom restrict object allow export product list price system classifi tantamount ban export champagn quot term quot resembl present situat wholesal allow export claus price export higher claus price term prevail spain likewis distil uk custom charg price depend resold insid unit kingdom commiss declar price term amount indirect export prohibit render sale member state difficult gosm martel commiss held martel discount system made export expens profit contrari articl object effect protect higher price level franc result govern intervent form price freez price control impedi parallel import result dual price system prohibit commiss decis pittsburgh corn gw contest claus compar dual price argu nation author determin level set price involv domest claus price impos level argument overlook fact pharmaceut compani negoti power discuss price domest sale discuss open basi price propos made compani spanish author compani base propos cost includ relat amp articl royal decre expressli refer cost involv amp includ complet cost account recit propos negoti compani appli price increas prove quot mandatori modif social sanitari technic econom budgetari statu quot recit possibl obtain price increas theoret materialis except product claim prime candid parallel trade gw manag obtain substanti price increas price increas serev imigran lamict ventolin juli provid tell exampl recit gw admit manag align domest price sever lamict imigran spain european averag price level argu benefit price increas neutralis simultan reduct price zantac matter gw sa propos reduct exchang price increas abovement product time zantac event patent unit kingdom member state face price competit form gener product illustr spanish author leav room real price bargain set price unilater compani negoti industri price nation author decid effect charg lower price gw sa sold product variat sever price lower authoris price case gw sa set commerci price maximum allow restrict object court justic court instanc qualifi agreement export ban dual price system limit parallel trade restrict competit quot object quot prohibit articl assess actual effect principl elig exempt pursuant articl refer made judgment nv iaz intern belgium commiss sandoz commiss recent volkswagen commiss case court instanc upheld commiss decis classifi measur make parallel import difficult exclud altogeth restrict quot object quot includ measur reduc bonu grant retail case export reduc incent engag parallel trade gw sale condit entail restrict competit quot object quot mean articl settl case law purpos applic articl account actual effect agreement object prevent restrict distort competit common market commiss requir show actual anti competit effect anti competit object conduct question prove sake complet commiss undertaken analysi assess sale condit legal econom context claus produc restrict effect competit tabl set detail impact gw sale condit parallel trade spain member state luxembourg gw lead product gw consid subject parallel trade recit emerg tabl claus price exclud trade make econom uninterest wholesal case case account wholesal cost percentag increas slightli wholesal cost margin ad domest export price case cost margin scenario case show agreement produc restrict effect competit exclud limit possibl parallel trade recit claus compens distort competit creat spain commiss reject gw argument claus compens distort competit creat spain essenti reason summaris develop detail appli articl treati free movement good court justic consist condemn state measur restrict parallel import medicin countri price lower provid incent pharmaceut compani undertak amp demonstr competit rule equal aim prevent partit common market nation line sector car contrast pharmaceut sector compani regulatori process compani reli differ nation regul justifi restrict parallel trade differ nation price regul underli polici object overst present case fourth simplist refer conflict nation price regul unilater state measur pharmaceut compani impos compani negoti power vi vi nation author case law articl pharmaceut sector merck primecrown court explicitli state quot imposit price control factor condit distort competit member state circumst justifi derog principl free movement good quot case court prevent pharmaceut produc invok uk patent stop parallel import spain product enjoi patent protect subject govern price control centrafarm winthrop court state quot matter signific exist export import member state price differ result government measur adopt export state view control price product quot court held centrafarm winthrop merck primecrown undertak reli nation patent legisl restrict free movement good common market consent reason commun law permit undertak restrict free movement good mean privat law contract condit articl met begin establish articl articl deal type restrict parallel trade seek achiev goal market integr court observ merck stephar patent holder avail nation patent block parallel trade quot bring partit nation market contrari aim treati quot consten grundig court state articl design pursu treati fundament object abolish barrier member state oppos agreement undertak restor nation divis thin line member state measur privat compani measur intellectu properti case effect appli articl case prohibit privat action compani reli monopoli right member state grant articl prohibit unilater privat action articl logic appli concert action involv compani achiev result sirena eda court rule exercis trademark import member state articl obstacl applic articl exercis trademark poss element agreement concert practic mean articl court acknowledg exercis fall scope articl observ quot situat articl appli aris restrict agreement proprietor trademark successor titl enabl prevent import form member state quot analog sector price influenc nation regul sector commiss refus differ nation regul exculpatori factor compani restrict competit approach upheld court justic car sector commiss acknowledg member state tax regim differ consider lead high price differ differ stand genuin market integr interfer free price nonetheless commiss accept justif block parallel trade volkswagen held block exempt commiss regul ec june applic articl treati categori motor vehicl distribut servic agreement inapplic result concert action manufactur import aim restrict parallel trade car manufactur fiscal regulatori process substanti differ car price member state consequ trigger parallel trade pharmaceut compani involv regulatori process govern sale price argument car freeli trade good compar medicin parallel trade benefit final consum medicin separ argument address context articl conflict unit kingdom spain polici object overst professor rei studi argu parallel trade spain endang uk price compromis uk polici choic foster amp studi basic assumpt downward price recit foundat parallel trade constitut neglig percentag pharmaceut sale recit produc margin effect price target countri illustr fact tabl show long histori parallel trade price unit kingdom substanti higher member state proof uk price spanish import differ polici choic member state overst hand spanish regulatori author expressli pharmaceut compani propos price fulli reflect amp cost state relev statut hand unit kingdom encourag amp recognis afford price paragraph ppr scheme depart health recognis continu innov kei competit success research base industri wish encourag research develop suppli innov treatment benefit nh patient paragraph ppr scheme associ british pharmaceut industri abpi quot recognis public interest price pharmaceut product suppli nh fair reason quot introduct scheme depart health abpi state quot common interest ensur safe effect medicin reason term nation health servic strong effici profit pharmaceut industri unit kingdom quot wish promot amp nh appear equal concern price reason level demonstr gener price cut appli octob recit nh de facto encourag parallel trade respect reimburs pharmacist fix fee take account actual purchas price result pharmacist purchas cheaper parallel import product proportion receiv higher rate reimburs colleagu bui domest higher price product nh avow polici favour high price parallel import introduc quot cost quot system pharmacist margin fix proport actual price paid wholosal frontier econom studi ii gw admit introduc system unit kingdom govern avoid incent pharmacist bui lowest price measur nh order glaxo perceiv avoid unjust enrich pharmacist claw back reimburs pharmacist assumpt correspond level parallel trade effect intermediari pharmacist pharmacist import proportion speak claw back mechan pharmacist fact incent increas parallel import unit kingdom establish measur reduc parallel trade seek achiev world foster amp time creat possibl achiev save fact nh recent creat nation institut clinic excel recit show unit kingdom interest cost effect medicin negoti power pharmaceut compani vi vi nation author explain fact compani negoti price spanish govern manag achiev price increas invok justif set relev royal decre simplist regard pharmaceut compani price taker nation compet author set maximum price paragraph present case differ distil victual metro villeroi boch gw reli distil victual conclud sale condit agreement distil victual entail distort competit point make commiss found restrict competit distil victual simpli restrict theoret appreci mean articl point make regulatori framework case compar face gw point appreci restrict commiss highlight fact victual custom intern ship airlin orient duti free market segment restrict freedom choos custom term sale quot result real restrict quot oblig impos victual quot effect appreci restrict competit common market quot contrast claus gw condit sale impos restrict wholesal freedom action matter lot complaint demonstr declin sale demonstr restrict pure theoret appreci point regulatori framework note commun legisl put place clear segment duti free duti free market segment custom group travel identifi commun law bui duti free victual agreement aim consolid legal situat limit victual freedom sell duti free good special distribut channel segment stake interfer integr nation market present case start segment spain export market brought commun nation legisl amend lei de medicamento limit spanish maximum price product dispens spain leav discret pharmaceut compani appli higher price export specif regim legal reserv claus price spanish market gw agreement wholesal segment creat gw sale condit directli lead compartmentalis common market metro villeroi boch relev deal contract claus address type price differenti vertic integr wholesal benefit vi vi retail purchas good wholesal present case price differenti creat agreement manufactur wholesal countri impact competit export wholesal intermediari oper level distribut chain member state price differenti interfer market integr unlik metro villeroi boch note metro court allow mainten price differenti condit system reinforc structur rigid market claus restrict opportun parallel trade creat currenc fluctuat gw acknowledg detriment effect parallel trade ist distribut pharmaceut product quot excus toler reflect work free market quot differ result quot exchang rate fluctuat lower cost distribut quot gw contend price differ sale condit seek tackl result member state intervent intervent distort competit appreci british pound period gw suppli data parallel trade product tell stori point recit gbp esp exchang rate rose januari decemb repres appreci gbp esp gap consider wider januari april month gw sa notifi sale condit april exchang rate risen constantli risen octob conclud appreci gbp major factor caus price differ trigger parallel trade spain unit kingdom gw maintain price differ result differ spanish british regulatori system import currenc fluctuat appreci british pound increas parallel import unit kingdom illustr comparison spanish sourc import import sourc countri unit kingdom period absolut volum spanish sourc import increas share import unit kingdom remain stabl conclud appreci british pound attract import sourc alleg discrep spanish uk regulatori system plai materi role process appreci restrict competit gw sale condit restrict competit appreci effect number reason firstli affect spanish pharmaceut wholesal wholesal respons sale gw product spain recit product cover gw high market share spain target countri emerg annex decis gw hold substanti atc level market share product affect spanish price system prime candid parallel trade recit true becotid beclofort flixotid serev ventolin belong class bronchodil asthma imigran case commun market share mark market share unit kingdom consid gw main target countri exce becotid beclofort flixotid serev ventolin imigran commun wide uk market share high product zofran zylor anti herp product zovirax valtrex final gw group largest pharmaceut produc europ world reflect group high turnov figur recit appreci effect trade member state agreement capabl affect trade member state appreci extent forese suffici degre probabl basi set object element law fact influenc directli indirectli potenti pattern trade member state hinder attain object singl market object effect sale condit restrict prevent parallel export trade member state affect wai seal market origin export spain hand protect destin market member state market cover commun sale condit concern entir spanish market agreement type extend territori member state natur effect reinforc compartmentalis market nation basi hold econom interpenetr treati intend bring gw admit effect argu system reduc lost revenu gw plc unit kingdom gbp million month applic spain articl treati gener observ combin applic articl articl commiss respond gw argument relat subsidiar articl treati recit address claim sale condit compens distort competit creat spain refer social econom cohes articl treati paragraph gw point signific delai product launch spain due artifici low price prevail argument suggest parallel trade caus allegedli low price exacerb delai problem argument address context condit set articl consum benefit final gw argument competit commun pharmaceut industri promot research technolog develop recit overlap argument advanc context condit articl technic progress argument address context judgment merck primecrown centrafarm winthrop case court state member state principl subject derog set articl articl cassi de dijon case law unilater adopt measur restrict import good member state good lawfulli market member state distort competit result differ nation regul sourc target countri tackl commun wide harmonis measur enact commun institut gw centrafarm winthrop commun institut altern tackl problem adoptin measur competit field point make merck primecrown court longer centrafarm winthrop languag exercis power competit field importantli languag suggest commiss applic articl privat parti rais obstacl parallel trade pharmaceut product argu object justif commiss examin applic articl cassi de dijon justif ground assess legal public measur imped parallel trade product notifi parti provid evid restrict competit result notifi agreement fulfil condit articl treati emerg recit commiss carefulli examin gw sale condit spain meet condit set articl quot bilan économiqu quot argument gw argu commiss weigh benefici effect sale condit promot technic progress improv distribut restrict effect competit commiss deni assess agreement articl involv balanc exercis benefit achiev parti agreement restrict competit caus text articl reflect balanc exercis incorpor quot posit condit quot quot neg condit quot concern benefit deal restrict indispens lead elimin competit substanti part product question establish case law condit set articl cumul met agreement consid exempt carri balanc exercis commiss convinc notifi agreement genuin contribut achiev benefit claim promot technic progress improv product distribut allow consum fair share benefit case gw proven claus sale condit make contribut shown convinc evid parallel trade affect gw amp budget event proof parallel trade minim effect budget gw demonstr parallel trade caus undu harm gw distributor locat spain consum spain circumst balanc test event commiss undertak balanc exercis posit effect gener sale condit outweigh neg effect produc integr nation market commun gw recognis sale condit partit market frontier econom studi gw make clear distinct call quot low price quot quot high price quot countri specif observ condit set articl import note notifi parti justifi restrict competit result notifi agreement demonstr restrict fulfil condit articl treati commiss prove intervent restrict competit produc benefit consum welfar restrict issu case constitut attempt partit common market principl restrict exempt articl gw fail provid suffici evid restrict competit result sale condit benefit exempt condit technic progress gw argu parallel trade caus loss amp revenu lost due parallel trade revenu spent develop innov product absenc trade gw claus sale condit aim remedi situat restrict parallel trade combat parallel trade sale condit creat extra financi resourc amp promot technic progress commiss view gw proven causal link parallel trade amp invest event overst magnitud impact parallel trade invest impact parallel trade amp causal link commiss disput amp import paramet competit pharmaceut sector financ evid parallel trade caus reduct gw amp budget prevent budget grow respect commiss offer observ parallel trade profit matter discret pharmaceut compani decid invest amp save hypothet make prevent parallel trade automat lead higher amp invest conceiv save ad compani profit gener extra profit justifi exempt regard gw argument condit exempt fulfil agreement contribut increas revenu firm engag amp condit case meaningless natur agreement restrict competit increas firm earn parallel trade cost gw admit quot parallel trade kei driver decis amp quot seri factor influenc decis amp expenditur includ gw admit gener level current profit expect profit product amp pipelin interest rate exchang rate volatil uncertainti futur demand parallel trade impact revenu profit reason pharmaceut compani react loss revenu result parallel trade cut amp budget budgetari item context born mind amp cost turnov remain sale cost administr cost profit illustr figur basi turnov gbp billion gw financi record show gbp billion cost sale gbp billion sell administr cost gbp billion amp profit gbp billion amp main factor competit pharmaceut compani save made gw expect cut expenditur budgetari item repres high cost import competit posit part substanti profit amp purpos pattern parallel trade amp expenditur gener parallel trade pharmaceut product realiti year amp expenditur grew tremend gw admit amp budget increas time relationship parallel trade gw product gw amp gw contend parallel trade signific impact revenu year alleg magnitud parallel trade problem gw address recit stage suffici note gw amp expenditur increas turnov turnov reduc expenditur absolut term revenu declin gw confirm revenu suffer expiri patent zantac zovirax amp expenditur continu increas rel term year turnov causal link identifi parallel trade amp year gw qualifi problemat amp project postpon abandon result parallel trade gw refer product significantli delai abandon product pre clinic phase time decis abandon made constitut high risk project pre clinic phase year prior market introduct gw assert due lack financi resourc shift riski project occur cancel high risk product yield biggest benefit futur patient note proof high risk project automat yield greatest benefit patient gw state natur quot high risk quot project li fact project constitut quot unproven mechan treat diseas quot qualiti project exist inform provid gw conserv conclus project greater chanc continu gw gain higher sale revenu profit add gw loss revenu stem specif parallel trade increment effect chanc specul parallel trade commun migrat amp usa nexu loss revenu result parallel trade commun migrat amp countri usa pharmaceut compani pursu amp activ global scale reason locat chosen research develop multipl complex commun singl market pharmaceut state product unit state america higher europ point favour legisl condit patent protect biotechnolog reduct earn caus parallel trade event commun state migrat trend previou year chang impact parallel trade amp magnitud price spain consider lower commun averag commiss acknowledg price level exist commun purpos decis commiss object group germani unit kingdom denmark sweden finland ireland austria high price countri belgium portug itali franc greec spain countri lower price commiss accept member state spain singl sourc parallel trade quot problem quot tabl spanisch price heavili parallel trade product dramat lower commun averag price gw attempt inflat price gap spain member state unit kingdom weight price level member state market size parallel trader make decis sell primarili basi price differ basi size target market reason simpl arithmet averag price repres weight parallel trace cyclic essenti caus currenc fluctuat gw singl spain main sourc countri parallel trade warrant special price polici commiss emphasis main target countri parallel import unit kingdom consider appreci nation currenc magnitud parallel trade problem gw plc appear currenc fluctuat price level spain recit respect recal british pound appreci spanish peseta octob pound start rise april gw notif januari decemb volum parallel trade unit kingdom sourc compar volum parallel trade spain period share spain sourc import increas absolut term found remain stabl commun law undertak invok effect currenc fluctuat justifi limit parallel trade principl longestablish explain commiss decis volkswagen commiss commun impact currenc fluctuat singl market behaviour constitut clear infring commun law gw plc loss revenu insignific rel gw amp expenditur gw plc estim spain sourc parallel trade lead product unit kingdom caus net loss gbp million take account extra revenu sale spain recit repres reduct amp budget gbp million pre tax profit recit whilst commiss disput direct causal link lost revenu reduct amp expenditur event consid reduct claim gw minim spread year concern compar gw total amp expenditur loss repres figur lost revenu uk sale base data annex gw notif exagger respons decemb gw reduc quot gross quot uk loss result spain sourc import lead product gbp million gbp million appli quot forex adjust quot oral hear februari respons formal request inform gw state gbp million reflect real estim loss real loss allegedli lower sale condit forc spain april recit evid direct causal link lost uk sale result parallel trade spain reduct amp refer recit illustr magnitud problem condit improv distribut gw put forward argument demonstr parallel trade detriment distribut pharmaceut product firstli parallel trade disrupt distribut system prevent manufactur plan distribut ration parallel trade lead situat undersuppli sourc countri oversuppli target countri thirdli parallel trade enhanc risk late introduct innov product low price countri sale condit remedi situat ensur gw ceas commercialis product spain parallel trade disrupt gw distribut system gw argu parallel trade remov incent mean wholesal locat spain provid level servic remuner gw provid exampl servic elabor extent produc requir pai servic outlin gw product distribut independ wholesal wholesal set resal price take account level servic provid parallel trade disrupt gw abil plan distribut ration gw argu parallel trade lead oversuppli target countri parallel trade unit kingdom product shortag sourc countri spain elabor argument provid evid show causal link parallel trade alleg shortag suppli spain shortag result pharmaceut compani deliber polici compani threat discontinu suppli parallel trade continu serv justif restrict competit undersuppli correct preserv possibl parallel import rais obstacl gw argument amount alloc effici optim suppli decis singl firm market divid competit forc plai commiss share view event gw fail give exampl product shortag spain exampl introduc product spanish market lower price sale spain make posit contribut gw profit gw simpli submit press clip spanish newspap refer gener potenti danger shortag due parallel trade press report octob state ministri health awar problem gw refer commun spanish medicin agenc spanish autonom commun associ pharmaceut cooper refer equal vagu event nation law mean prevent shortag impos oblig wholesal suffici volum product stock parallel trade delai product launch spain gw refer london econom studi report averag introduct delai countri unit kingdom germani netherland month spain franc delai rang month spain twelv month franc submit im data suggest product delai spain extend quarter compar quarter unit kingdom question parallel trade consequ measur limit trade contribut reduc market delai commiss see causal link product launch depend number factor outcom price discuss pharmaceut compani nation author fact gw cite main reason late introduct product spain incident illustr compani full discret decid profit introduc product market gener gw admit reason product launch delai reimburs delai market decis price negoti simpli lack demand reason relat parallel trade compel evid launch gw product spain delai begin gw activ delai spain delai sweden delai netherland delai denmark delai germani delai franc highest number delai occur call high price countri strike unit kingdom market introduct delai parallel trade caus delai gw give reason delai unit kingdom delai explain quot reimburs delai quot quot market delai quot refer decis gw local oper compani launch product refer price neg impact refer price discuss product quot reimburs delai quot caus necess gw market authoris submit file reimburs negoti gw author protract reason link parallel trade phenomenon event fact compani decid threaten launch product lowpric countri serv justif restrict competit condit benefit consum recit notifi parti substanti restrict competit propos put place contribut improv product distribut promot technic econom progress set articl consum receiv fair share benefit commiss gw requir prove intervent propos restrict competit enhanc consum welfar gw notifi system fulfil criteria articl commiss decis gw argu consum benefit sale condit term enhanc research develop improv distribut spanish consum benefit directli extent agreement ensur gw product spain condit ensur gw maintain invest amp produc substanti benefit past consider potenti futur notifi sale condit ensur unit kingdom industri social polici decis encourag research develop frustrat spanish polici implic argument reiter argument put forward gw demonstr sale condit fulfil condit articl explain recit gw fail demonstr causal link restrict competit object set condit establish differ polici goal unit kingdom spain overst recit event privat compani safeguard government polici choic restrict competit gw demonstr restrict parallel tade achiev benefit requir condit condit articl fulfil examin gw insist pharmaceut product parallel trade achiev benefit consum consum welfar perspect gw consum posit gw system parallel trade gw assert specif parallel trade pharmaceut product commod car fi equip patient deriv benefit parallel trade form lower price gw patient reimburs nation health organis organis real consum econom term purchas drug unit kingdom concern gw sale condit spain allegedli benefit nh enabl maintain polici promot amp save made nh claw back mechan gbp million parallel import outweigh gw plc lost sale gbp million respect recal notifi parti justifi restrict competit show agreement fulfil condit articl commiss prove intervent restrict increas consum welfar sake complet commiss address number argument gw contest intervent competit author serv gener consum welfar interest sale condit cover export member state unit kingdom benefici effect parallel trade illustr broader basi parallel trade product offer sourc suppli import consum point view brand patent product involv patent medicin enjoi protect year case altern parallel trade offer sourc competit gw unqualifi assert natur reimburs system preclud benefit patient parallel trade incorrect patient benefit directli parallel trade pai full amount purchas price reimburs partial express percentag actual purchas price contrast flat fee german patient pai full price contracept eaepc refer contracept marvelon minulet parallel trade lead direct save patient gw contest exact amount price differ parallel trade domest sold contracept admit parallel trade cheaper partial reimburs payment exist member state patient receiv reimburs calcul percentag actual purchas price belgium franc parallel trade benefit directli final observ high price countri netherland de facto provid incent parallel trade cost save effect health care budget reimburs form flat fee pharmacist intermediari benefit purchas cheaper parallel trade product purchas yield higher profit notion consum restrict final consum patient interest wholesal pharmaci nation health budget insur scheme account possibl pharmaci pass part save client annual bonus authoris nation legisl rule ultim patient pai nation health system public health system financ contribut gener tax save made scheme purchas cheaper parallel trade drug indirectli benefit scheme member emerg tabl member state enact measur provid incent parallel trade lead save uk reimburs system fix reimburs fee claw back system recit de facto incent intermediari pharmaci purchas cheaper parallel trade drug shown member state give specif incent parallel trade order achiev cost save health care budget denmark germani sweden recit serv condit indispens condit articl cumul commiss assess individu condit articl nonetheless note sale condit fulfil condit evid achiev object promot technic progress improv distribut contribut indispens attain object analys fourth condit elimin competit respect substanti part product question note recit gw put forward argument condit submit argument reject event lead product affect sale condit zofran flixonas zovirax imigran gw hold substanti market share member state iii conclus reason conclud sale condit object effect restrict competit affect trade member state appreci extent mean articl meet condit exempt pursuant articl gw requir pursuant articl regul bring infring end gw sa file origin notif gw plc file supplementari notif juli notif gw plc explain effect ownership control gw sa recit letter octob gw plc request correspond respect notif address copi subsidiari gw sa subsequ correspond includ statement object adopt juli address gw plc merger smithklin beecham compani gw plc chang decis address glaxosmithklin plc unit kingdom adopt decis articl glaxo wellcom infring articl treati enter agreement spanish wholesal oper distinct price charg wholesal case domest resal reimburs drug pharmaci hospit higher price charg case export member state articl request glaxo wellcom exempt agreement refer articl pursuant articl treati reject articl glaxo wellcom immedi bring end infring refer articl refrain repeat measur constitut infring refrain adopt measur similar object effect articl glaxo wellcom inform commiss month notif decis step bring infring end articl decis address glaxosmithklin plc glaxo wellcom hous berkelei avenu greenford middlesex ub nn unit kingdom brussel commiss mario monti member commiss oj oj oj text decis refer quot articl treati quot refer ec treati articl articl articl statut aseprofar free translat english commiss decis case iv glaxo wellcom smithklin oj full list annex origin notif document ter note page number bracket refer page commiss file iv refer complaint file case number page number respons gw inform request april annex respons gw annex supplementari notif gw juli annex part text edit ensur confidenti inform busi secret disclos part squar bracket ibid ibid respons glaxo respons spain pharma novemb inform request octob case respons aseprofar novemb inform request octob case pp seq respons gw decemb inform request octob annex respons gw februari inform request januari pp fax aseprofar commiss februari march march april case pp pp london econom studi gw slide present oral hear decemb tabl featur london econom studi london econom studi execut summari notif repli annex detail price increas obtain gw sa repli annex lamict packag form tablet replac packag form tablet gw respons decemb supplementari notif gw juli annex repli annex repli annex respons decemb inform work document featur annex efpia comment case iv novemb london econom studi gw present oral hear mention london econom studi inform work document featur annex efpia comment case iv novemb recit die london school econom studi london econom studi percentag paragraph london econom studi sca report quot konkurren vid försäljnig av läkemedel quot pp bgbi part webpag gesundheitsministerium dialog gesundheit question import patent product german law freeli price subject reimburs cap health insur scheme pai fix price excess price born patient quot festbeträg quot quot parallel import strategi quot scrip report april pjb public frontier econom studi origin notif supplementari notif gw juli annex notif juli gw plc respons decemb question commiss formal request inform octob annex supplementari notif juli ibid annex ibid annex supplementari notif juli request inform januari product flixotid inhal mg dose imigran inject ml serev accuhal mg dose product flixotid mcg inhal dose flixotid mcg inhal dose flixotid mcg accuhal dose flixotid mcg accuhal dose supplementari notif juli gw estim quot parallel import spain account sale parallel import uk quot comparison figur tabl annex notif suggest account period recit decis case respons eaepc commiss inform request march section pp neg clearanc section pp exempt pp pp commiss decis eec case iv saba oj upheld court justic case metrov commiss quot metro quot ecr commiss decis eec case iv distil victual oj recit commiss decis eec oj recit calcul basi domest sale sale stem parallel import exclud total uk sale amount gbp million annex gw notif juli sale domest meant discount gbp million parallel import account gbp million ibid leav gbp million domest sale gw entitl discount amount correspond gbp million differ gbp million gbp million minu gbp million total parallel import gbp million import spain repres gbp million annex gw notif juli recit gbp million lost discount directli attribut import join case ecr case ecr repli london econom studi pp footnot point amp ratio constant year gbp billion billion spent gbp billion spend billion sourc annual report slide present glaxo oral hear decemb footnot supplementari notif gw juli professor corchon studi pp case submiss eaepc decemb case commiss decis ec case iv ciba geigi sandoz oj recit commiss notic definit relev market purpos commun competit law oj recit intend supplementari notif council regul eec juli lai commun procedur authoris supervis medicin product human veterinari establish european agenc evalu medicin product oj regul amend regul ec oj execut summari lse studi introduct commiss decis eec case iv sandoz oj case sandozv commiss ecr commiss decis eec case iv distil compani limit condit sale price term oj point commiss decis eec case iv moët chandon london oj paragraph commiss decis eec case iv gosm martel dmp oj paragraph commiss decis eec case iv pittsburgh corn europ formica belgium hertel oj repli annex letter gw ministri health april repli annex letter gw ministri health april annual report gw gw state zantac increas pressur gener competit respons februari serev acc gw charg esp unit authoris inh esp unit charg compar authoris price esp inh esp unit authoris charg repli annex present ptw respons decemb annex gw indic show differ commerci authoris price product beclofort mg inh commerci price authoris price beconas commerci price autoris price becotid commerci price autoris price join case ecr paragraph case ecr ii paragraph case volkswagenv commiss paragraph join case merck amp primecrown limit paragraph case bristol myer squibbv paranova ecr paragraph case centrafarm bv de peijperv winthrop bv ecr paragraph case ecr paragraph case consten grundig verkauf gmbh ecr case sirena srl veda srl ecr paragraph case emi record limitedv cb schallplatten gmbh ecr paragraph join case heintz van landewyk sarlv commiss ecr paragraph court acknowledg belgian taxat system definit influenc competit refus accept restrict competit base reason commiss report car price european union cop show price differ honda sold denmark franc pp tax notic regul eec applic articl categori motor vehicl distribut servic agreement oj commiss specifi withdraw benefit block exempt select distribut network price differ exce indic differ chiefli due oblig subscrib approv dealer support attempt block parallel trade notic remain applic adopt regul ec press releas ip decis ec case iv opel oj commiss prohibit measur block parallel trade price differenti result tax burden commiss decis ec case iv volkswagen oj paragraph decis upheld court instanc case volkswagen agv commiss ecr ii oj articl royal decre recit repli annex ppr frontier econom studi ii case metro sb großmärktev commiss commiss decis eec supplementari notif juli volkswagenag commiss op cit case parker penv commiss ecr ii paragraph volkswagen agv commiss op cit case remia bv othersv commiss ecr paragraph respons gw februari case publish associ commiss ecr ii paragraph case matra hachett sa commiss ecr ii paragraph frontier econom studi case matra sa hachett commiss paragraph frontier econom studi ii ibid gw annual report professor corchon studi case supplementari notif gw juli footnot frontier econom studi ii annual report year report repli respons februari respons februari pp annex seq respons februari commiss decis case iv hoechst rhône poulenc oj paragraph final chapter frontier econom studi annex repli repli frontier econom studi annex repli seq seq op cit recit final total amp expenditur amount gbp billion gbp billion gbp billion notif repli annex quot drug export prevent diabet obtain insulin quot la razon rebutt gw eaepc comment februari lei articl oficio ministri health consum date april london econom studi repli annex supplementari notif gw juli annex respons decemb annex year ventolin respir year imigran inject year imigran tab ventolin nebul remain half year respons gw decemb ibid supplementari notif case submiss quot parallel trade pharmaceut quot letter februari matra sa hachett commiss op cit annex product cover glaxo wellcom sa condit sale spanish denomin alquen mg comp efervescent bacisporín pomada gramo beclofort inhalador mcg dosi beconas sprai nasal acuoso mcg becotid inhalador mcg busulfán wellcom mg comp busulfán wellcom mg comp curoxima mcg vial amp ml curoxima mg vial amp ml daraprim comp dexnón mcg mg comp flixonas mg sprai nasal dosi flixotid mcg accuhal dosi flixotid mcg inhalador dosi flixotid mg inhalador dosi flixotid mg accuhal dosi fortam gr im iv amp ml fortam mg vial amp ml greosín mg comp greosín mg comp igril comp imigrán mcg comp imigrán mg ini jeringa cut kemadrén comp lacipil mg comp lamict mg comp lamict mg comp lamict mg comp lamict mg comp lanacordín ampolla amp lanacordín comprimido comp lanacordín comprimido comp lanacordín pediátrico ml sol leukerán mg comp leukerán mg comp melfalán mg comp melfalán mg comp mercatopurina wellcom comp metoxamina wellcom mg amp ini otosporín ml pilorid mg comp pro actidil comp serev inhalador mcg dosi serev inhalador mcg dosi serev accuhal mcg dosi tioguanina wellcom comp trandat mg comp trandat mg comp valtrex mg comp valtrex mg comp ventolín sol resp ml mg ventolín mg comprimido ventolín mg comprimido ventolín inhalador mcg ventolín inyect mg ml amp ventolín jarab mg ml ml wellferón mu vial de ml wellferón mu vial de ml wellferón mu vial de ml zantac mcg comp zantac mcg comp zinnat mg comp zinnat mg sobr zinnat mg ml susp zinnat mg comp zinnat mg sobr zinnat mg comp zinnat mg sobr zofrán mg comp zofrán mg comp zofrán mg comp zofrán mg comp zovirax mg comp disper comp zovirax mg comp disper comp zovirax crema gr zovirax crema gr zovirax pom oftalm gr zovirax suspensión fort ml zovirax suspensión fort ml zylor mg comp zylor mg comp zylor mg comp annex gt tabl gt commun dk po lu ir fl busi secret disclos annex gbp esp exchang rate march novemb gt tabl gt sourc europa infor euro